litlas
Log inCreate account

S E Salmon

Active 1967–1998

Affiliations
University of ArizonaThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
Also published as
S. E. Salmon
31
Papers
5,843
Citations
31
h-index
31
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for S E Salmon1968: 4 citations1969: 4 citations1970: 14 citations1971: 9 citations1972: 9 citations1973: 6 citations1974: 4 citations1975: 3 citations1976: 5 citations1977: 2 citations1978: 13 citations1979: 4 citations1980: 12 citations1981: 9 citations1982: 11 citations1983: 19 citations1984: 16 citations1985: 21 citations1986: 23 citations1987: 13 citations1988: 7 citations1989: 20 citations1990: 38 citations1991: 53 citations1992: 43 citations1993: 43 citations1994: 31 citations1995: 64 citations1996: 64 citations1997: 44 citations1998: 18 citations1999: 28 citations2000: 35 citations2001: 27 citations2002: 26 citations2003: 40 citations2004: 29 citations2005: 21 citations2006: 29 citations2007: 24 citations2008: 13 citations2009: 15 citations2010: 13 citations2011: 19 citations2012: 8 citations2013: 9 citations2014: 16 citations2015: 7 citations2016: 11 citations2017: 5 citations2018: 7 citations2019: 17 citations2020: 14 citations2021: 8 citations2022: 5 citations2023: 9 citations2024: 8 citations2025: 5 citations
  • 1 year (4 citations) is not shown (dated before this author's first paper)

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology3%
  • Chemistry0.9%
  • Materials Science0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other2.8%

Topics

  • Drug Transport and Resistance Mechanisms20.4%
  • Multiple Myeloma Research and Treatments17.1%
  • Cancer Treatment and Pharmacology10.1%
  • Cancer therapeutics and mechanisms7.8%
  • Pharmacological Effects and Toxicity Studies5.8%
  • Protein Degradation and Inhibitors5.5%
  • Other33.3%

Frequent coauthors

All papers

Open in search

Loading papers…

S E Salmon | Litlas